Published in Psychiatr Clin North Am on March 01, 2007
Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder. J Psychiatr Res (2009) 1.09
Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder. Dialogues Clin Neurosci (2008) 0.99
Toward achieving optimal response: understanding and managing antidepressant side effects. Dialogues Clin Neurosci (2008) 0.95
Pretreatment anterior cingulate activity predicts antidepressant treatment response in major depressive episodes. Eur Arch Psychiatry Clin Neurosci (2013) 0.90
Multiweek resting EEG cordance change patterns from repeated olfactory activation with two constitutionally salient homeopathic remedies in healthy young adults. J Altern Complement Med (2012) 0.80
The antidepressant treatment response index and treatment outcomes in a placebo-controlled trial of fluoxetine. J Clin Neurophysiol (2011) 0.78
The Evolution of Homeopathic Theory-Driven Research and the Methodological Toolbox. Am Homeopath (2015) 0.78
The effectiveness of prefrontal theta cordance and early reduction of depressive symptoms in the prediction of antidepressant treatment outcome in patients with resistant depression: analysis of naturalistic data. Eur Arch Psychiatry Clin Neurosci (2014) 0.76
Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry (2011) 3.34
Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy. Neurology (2013) 2.62
Changes in brain function of depressed subjects during treatment with placebo. Am J Psychiatry (2002) 2.39
Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depress Anxiety (2012) 2.23
Yoga as a complementary treatment of depression: effects of traits and moods on treatment outcome. Evid Based Complement Alternat Med (2007) 2.22
Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D. J Clin Psychiatry (2005) 1.99
American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias. Second edition. Am J Psychiatry (2007) 1.79
Growth modeling with nonignorable dropout: alternative analyses of the STAR*D antidepressant trial. Psychol Methods (2011) 1.49
A web-based data management system to improve care for depression in a multicenter clinical trial. Psychiatr Serv (2002) 1.48
Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant. J Clin Psychiatry (2004) 1.42
Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study. Psychiatry Res (2009) 1.40
Site versus centralized raters in a clinical depression trial: impact on patient selection and placebo response. J Clin Psychopharmacol (2010) 1.29
Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. Psychiatry Res (2009) 1.18
Biomarkers to predict antidepressant response. Curr Psychiatry Rep (2010) 1.14
Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry (2007) 1.14
Trigeminal nerve stimulation in major depressive disorder: first proof of concept in an open pilot trial. Epilepsy Behav (2011) 1.11
fMRI activation in the amygdala and the orbitofrontal cortex in unmedicated subjects with major depressive disorder. Psychiatry Res (2010) 1.10
Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder. J Psychiatr Res (2009) 1.09
A role for profiles of patient-specific depression characteristics and socioeconomic factors in the prediction of antidepressant treatment outcome. J Clin Psychiatry (2015) 1.07
Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology (2002) 1.06
Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study. J Psychiatr Res (2005) 1.05
Trigeminal nerve stimulation: seminal animal and human studies for epilepsy and depression. Neurosurg Clin N Am (2011) 1.04
Longitudinal progression of subclinical structural brain disease in normal aging. Am J Geriatr Psychiatry (2004) 1.04
Association between quantitative EEG and neurocognition in methamphetamine-dependent volunteers. Clin Neurophysiol (2004) 1.03
Trigeminal nerve stimulation in major depressive disorder: acute outcomes in an open pilot study. Epilepsy Behav (2013) 1.02
Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder. J Clin Psychopharmacol (2009) 1.01
Cognitive and physiologic correlates of subclinical structural brain disease in elderly healthy control subjects. Arch Neurol (2002) 0.98
Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression. Am J Psychiatry (2006) 0.96
Characteristics of insured and noninsured outpatients with depression in STAR(*)D. Psychiatr Serv (2005) 0.93
Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression. Psychopharmacology (Berl) (2004) 0.93
Treatment of patients with substance use disorders, second edition. American Psychiatic Association. Am J Psychiatry (2006) 0.93
White matter injury, neural connectivity and the pathophysiology of psychiatric disorders. Dev Neurosci (2002) 0.93
A new paradigm for the prediction of antidepressant treatment response. Dialogues Clin Neurosci (2009) 0.93
Midline and right frontal brain function as a physiologic biomarker of remission in major depression. Psychiatry Res (2009) 0.92
The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorder. Front Hum Neurosci (2013) 0.92
Quantitative EEG abnormalities in recently abstinent methamphetamine dependent individuals. Clin Neurophysiol (2003) 0.92
A genome-wide association study of a sustained pattern of antidepressant response. J Psychiatr Res (2013) 0.90
Predictive socioeconomic and clinical profiles of antidepressant response and remission. Depress Anxiety (2013) 0.90
Brain electrical source differences between depressed subjects and healthy controls. Brain Topogr (2008) 0.89
Does the clinical course of depression determine improvement in symptoms and quality of life? J Nerv Ment Dis (2006) 0.89
Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression. Clin Neurophysiol (2009) 0.89
Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study. J Clin Psychiatry (2005) 0.87
Resting-state quantitative electroencephalography reveals increased neurophysiologic connectivity in depression. PLoS One (2012) 0.87
Relationship between medical student perceptions of mistreatment and mistreatment sensitivity. Med Teach (2012) 0.86
Baroreflex mechanisms in major depression. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.86
A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period. J Clin Psychiatry (2014) 0.86
Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain. Psychosomatics (2005) 0.85
Early adverse events and attrition in selective serotonin reuptake inhibitor treatment: a suicide assessment methodology study report. J Clin Psychopharmacol (2010) 0.85
Assessment of the feasibility of a rehabilitation intervention program for breast cancer survivors with cognitive complaints. Brain Imaging Behav (2013) 0.85
Aging and brain activation with working memory tasks: an fMRI study of connectivity. Int J Geriatr Psychiatry (2007) 0.84
Rostral anterior cingulate cortex activity and early symptom improvement during treatment for major depressive disorder. Psychiatry Res (2011) 0.82
Changes in brain function during administration of venlafaxine or placebo to normal subjects. Clin EEG Neurosci (2008) 0.81
Antidepressant treatment history and drug-placebo separation in a placebo-controlled trial in major depressive disorder. Psychopharmacology (Berl) (2015) 0.81
Neuromodulation for depression: invasive and noninvasive (deep brain stimulation, transcranial magnetic stimulation, trigeminal nerve stimulation). Neurosurg Clin N Am (2014) 0.80
Neurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placebo. Neuropsychopharmacology (2005) 0.80
Quantitative EEG abnormalities are associated with memory impairment in recently abstinent methamphetamine-dependent individuals. J Neuropsychiatry Clin Neurosci (2009) 0.80
Rhythms and blues: modulation of oscillatory synchrony and the mechanism of action of antidepressant treatments. Ann N Y Acad Sci (2015) 0.80
Rostral anterior cingulate activity in major depressive disorder: state or trait marker of responsiveness to medication? J Neuropsychiatry Clin Neurosci (2013) 0.79
Impact of antidepressant treatment history on clinical outcomes in placebo and medication treatment of major depression. J Clin Psychopharmacol (2010) 0.79
Quantitative electroencephalography biomarkers of cognitive complaints after adjuvant therapy in breast cancer survivors: a pilot study. Psychooncology (2014) 0.79
Neurophysiologic changes during estrogen augmentation in perimenopausal depression. Maturitas (2006) 0.79
Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial. J Clin Psychiatry (2013) 0.79
Estrogen replacement therapy is associated with less progression of subclinical structural brain disease in normal elderly women: a pilot study. Int J Geriatr Psychiatry (2002) 0.79
Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of quality of life outcome measures in clinical practice. CNS Spectr (2013) 0.79
Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: An Updated Systematic Review and Meta-analysis. J ECT (2016) 0.78
Use of clinical neurophysiology for the selection of medication in the treatment of major depressive disorder: the state of the evidence. Clin EEG Neurosci (2009) 0.78
The antidepressant treatment response index and treatment outcomes in a placebo-controlled trial of fluoxetine. J Clin Neurophysiol (2011) 0.78
Predictors of improved mood over time in clinical trials for major depression. Psychiatry Res (2004) 0.77
Influence of age, gender, health status, and depression on quantitative EEG. Neuropsychobiology (2005) 0.77
Manipulation of cigarette craving with transcranial magnetic stimulation. Biol Psychiatry (2011) 0.77
Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report. J Affect Disord (2011) 0.77
Does prior antidepressant treatment of major depression impact brain function during current treatment? Eur Neuropsychopharmacol (2012) 0.76
Pretreatment neurophysiologic function and ECT response in depression. J ECT (2004) 0.76
Effects of heart disease on depression treatment: results from the COMED study. Gen Hosp Psychiatry (2011) 0.76
Variation in neurophysiological function and evidence of quantitative electroencephalogram discordance: predicting cocaine-dependent treatment attrition. J Neuropsychiatry Clin Neurosci (2006) 0.76
Amygdala lateralization at rest and during viewing of neutral faces in major depressive disorder using low-resolution brain electromagnetic tomography. Clin EEG Neurosci (2010) 0.76
Brain functional changes and duloxetine treatment response in fibromyalgia: a pilot study. Pain Med (2009) 0.76